OPSENS SIGNS LANDMARK SUPPLIER AGREEMENT – EXPANDS OPTICAL SENSING TECHNOLOGY IMPACT WITHIN CARDIOLOGY SEGMENT

Quebec City, Quebec, April 30, 2019 – Opsens inc. (“Opsens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF) is pleased to announce it has entered into a supply agreement as part of its long-term collaboration with Abiomed, Inc. (“Abiomed”) for the Impella CP® heart pump. Abiomed has awarded Opsens a five-year agreement to supply a critical component for […]

Read More…

Visit Opsens at SCAI 2019

Learn more about the benefits of OptoWire® as a pressure guidewire to diagnose and treat with confidence at SCAI 2019 (Society for Cardiovascular Angiography & Interventions) by attending Opsens’ complimentary lunch  and educational symposium.  Register Now! The OptoWire features a large nitinol core with excellent torque response and deliverability. With the OptoWire you can diagnose and treat […]

Read More…

OPSENS – Q2 2019 REVENUES REACH $7.9 M, A 46% INCREASE

Quebec City, Quebec, April 11, 2019 – Opsens Inc. (“Opsens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF) today reported its results for the second quarter of 2019. Highlights Consolidated revenues totaled $7.9 M in the second quarter of 2019 compared with $5.4 M in the corresponding period in 2018, an increase of $2.5 M or 46%; Fractional […]

Read More…

This website uses cookies to ensure you get the best experience on our website.